icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
077JDkErnnr4Q4R3
Listen
